Document:

Employment Agreement

 EXHIBIT 10.10 
  
 NABI BIOPHARMACEUTICALS 
 5800 PARK OF COMMERCE BOULEVARD, N.W. 
 BOCA RATON, FLORIDA 33487 
  
 Effective as of April 1, 2004 
  
 Raafat Fahim Ph.D. 
 1180 S. Ocean Blvd #8F 
 Boca Raton, FL 33432 
  
 Dear Raafat: 
  
 You have agreed to serve as Senior Vice-President (SVP) Research, Technical and Production Operations for Nabi Biopharmaceuticals (“Nabi”) which term for
purposes of this Agreement shall include affiliates of Nabi Biopharmaceuticals. The following are the terms of such employment: 
  
 1. TERM: You will serve as a SVP Research, Technical and Production Operations for a period beginning as of the date hereof and ending on March 31, 2007,
unless your employment is sooner terminated as provided below (the “Employment Period”). In the event that your employment by the Company continues beyond the Employment Period, the terms and conditions of this Agreement shall continue
except that your continued employment by the Company may be terminated by either party upon thirty (30) days’ prior notice unless you and the Company shall have entered into a written agreement to the contrary.  
  
 2. SALARY: Your salary will be $260,000 per year, payable bi-weekly during the
Employment Period. Your salary will be subject to discretionary annual increases as determined by Nabi’s Board of Directors. 
  
 3. BONUS: You will be entitled to participate in Nabi’s VIP Management Incentive Program or any comparable bonus plan maintained by Nabi (“Bonus
Plan”). Your participation in the Bonus Plan shall be subject to the terms and conditions of the Bonus Plan. 
  
 Unless the Employment Period is terminated for “cause” pursuant to Section 7(B) (b) below, if the Employment Period ends during a calendar year, your bonus
compensation opportunity shall be pro rated based upon the number of full calendar months you were employed and the amount of bonus compensation which would have been payable with respect to such year pursuant to the Bonus Plan. If the
Employment Period is terminated pursuant to Section 7 (B)(b) below, no bonus compensation shall be payable with respect to the calendar year during which the Employment Period is terminated.  

 Bonus payments, if applicable, shall be payable within 120 days after the end of the relevant calendar year.

  
 4. AUTO ALLOWANCE: While an employee under the terms of this
Agreement, you shall receive an auto allowance of not less than $1200.00 per month. 
  
 5. BENEFITS: During the Employment Period, you will be eligible to participate in such fringe benefits programs as are accorded to other similarly situated Nabi employees. In addition, Nabi shall pay you an Executive Bonus,
grossed up for taxes, so that you can make a $12,000 contribution to your Supplemental Executive Retirement Plan (the “SERP”) and provide you at Nabi’s cost with term life insurance of $500,000 in excess of the term life insurance
coverage Nabi provides to its employees generally. Nabi shall cover the cost of financial planning services up to $3000.00/year. Nabi shall also pay your reasonable social dues at a single club. 
  
 6. DUTIES AND EXTENT OF SERVICES: 

 
 (A) During the Employment Period, you agree to devote substantially all of your working
time, and such energy, knowledge, and efforts as is necessary to the discharge and performance of your duties provided for in this Agreement and such other reasonable duties and responsibilities consistent with your position as are assigned to you
from time to time by the person to whom you report. You shall be located primarily in Nabi’s Boca Raton, Florida facilities, but shall travel to other locations from time to time as shall be reasonably required in the course of performance of
your duties. 
  
 (B) During the Employment Period, you shall serve as a SVP
Research, Technical and Production Operations. You shall have such duties as are delegated to you by the person to whom you report provided that such duties shall be reasonably consistent with those duties assigned to executive officers having
similar titles in organizations comparable to Nabi. 
  
 7.
TERMINATION: 
  
 (A) The Employment Period shall terminate upon
your death. You may also terminate the Employment Period upon thirty (30) days’ prior written notice to Nabi. Any termination pursuant to this Section 7(A) shall not affect any bonus compensation applicable to the year of such termination,
provided that, if applicable, any bonus compensation payable pursuant to Section 3 of this Agreement shall be pro rated as provided for in Section 3. 
  
 (B) Nabi may terminate the Employment Period (a) in the event Nabi reasonably determines that you are unable to perform the essential functions of your position, with or
without reasonable accommodation, for any three (3) consecutive months as the result of mental or physical incapacity or (b) for “cause”, which is defined as (i) acts of fraud or embezzlement or other felonious acts by you, (ii) your
refusal to comply with reasonable directions in connection with the performance of your duties as provided for in Section 6 of this Agreement after notice of such failure is delivered to you, (iii) failure to comply with the provisions of Section 9
or 10 of this 
  

 2 

 Agreement or (iv) your gross negligence in connection with the performance of your duties as provided for in this
Agreement, provided that, in the event of a proposed termination under clause (ii) or clause (iv) of this clause (B), you shall receive ten (10) days’ prior written notice of such proposed termination and within such period you shall be
afforded an opportunity to be heard by Nabi’s Board of Directors or a duly appointed committee of the Board as to whether grounds for termination under these clauses exists. 
  
 (C) Nabi may otherwise terminate the Employment Period upon thirty (30) days’ prior notice to you. 
  
 (D) Your confidentiality and non-competition agreements set forth in Sections 9 and 10 below
and your agreement to cooperate set forth in Section 11 below shall survive the termination of your employment regardless of the reasons therefor. 
  

	8.	SEVERANCE 

  
 (A) In the event that (a) your employment terminates pursuant to Section 7C or (b) after the expiration of the Employment Period, if your employment continues as provided in Section 1, either you give notice of
termination of employment to the Company or the Company gives you notice of termination of employment other than for cause (as defined above) or disability, and provided that (i) within thirty (30) days prior to the expiration of the Employment
Period Nabi had not offered to renew this Agreement on terms no less favorable to you than the terms then in effect, and (ii) within ninety (90) days following the expiration of the Employment Period Nabi has not tendered to you a new employment
agreement executed on behalf of Nabi and containing such no less favorable terms, you shall receive the benefits set forth in Sections 8B, 8C and 8D. In the event your employment terminates pursuant to Section 7B (a), or as a result of your death,
you shall receive the benefit set forth in Section 8D. Notwithstanding the foregoing provisions of this Section 8A, in the event your employment terminates under circumstances that entitle you to receive compensation and other benefits pursuant to
the April 1, 2004 Change of Control Severance Agreement between you and Nabi (the “Change of Control Severance Agreement”), you shall not receive the benefits set forth in Section 8B, 8C and 8D. 
  
 (B) Based on the effective date of such termination, Nabi will pay you your base salary as of
the effective date of such termination (“Severance Pay”) and maintain in effect such fringe benefits (including auto allowance) as are accorded to other similarly situated employees (to the extent allowed under, and subject to the
limitations of, applicable plans) for eighteen (18) months. Severance Pay shall be made in equal bi-weekly installments. 
  
 (C) The Company shall pay for executive outplacement services up to $18,000 by an organization selected by Nabi in its sole discretion. 
  
 (D) All of your non-vested stock options, restricted stock or similar incentive equity
instruments (“Options”) shall immediately vest. All such “Options” shall be exercisable for twelve (12) months past your termination date, except that no “Options” shall be exercisable beyond the original
“Option” expiration date. To the extent the terms of any “Options” are inconsistent with this Agreement, the terms of this Agreement shall control. 
  

 3 

 (E) All payments or benefits to you under this Section 8 (other than payments or benefits already accrued and otherwise
due under Nabi’s employee benefit plans or programs, or as a result of your death) will not be given unless you execute (and do not rescind) a written employment termination agreement in a form prescribed by Nabi, containing terms consistent
with this Agreement as well as a general release of all claims against Nabi and related parties with respect to all matters occurring prior to or on the date of the release, including (but not limited to) employment matters or matters in connection
with your termination. 
  
 9. CONFIDENTIALITY: You acknowledge that
your duties with Nabi will give you access to trade secrets and other confidential information of Nabi and/or its affiliates, including but not limited to information concerning production and marketing of their respective products, customer lists,
and other information relating to their present or future operations (all of the foregoing, whether or not it qualifies as a “trade secret” under applicable law, is collectively called “Confidential Information”). You recognize
that Confidential Information is proprietary to each such entity and gives each of them significant competitive advantage. 
  
 Accordingly, you shall not use or disclose any of the Confidential Information during or after the Employment Period, except for the sole and exclusive benefit of the
relevant company. Upon any termination of the Employment Period, you will return to the relevant company’s office all documents, computer electronic information and files, e.g., diskettes, floppies etc. and other tangible embodiments of any
Confidential Information. You agree that Nabi would be irreparably injured by any breach of your confidentiality agreement, that such injury would not be adequately compensable by monetary damages, and that, accordingly, the offended company may
specifically enforce the provisions of this Section by injunction or similar remedy by any court of competent jurisdiction without affecting any claim for damages. 
  
 10. NON-COMPETITION: 
  
 (A) You acknowledge that your services to be rendered are of a special and unusual character and have a unique value to Nabi the loss of
which cannot adequately be compensated by damages in an action at law. In view of the unique value of the services, and because of the Confidential Information to be obtained by or disclosed to you, and as a material inducement to Nabi to enter into
this Agreement and to pay to you the compensation referred to above and other consideration provided, you covenant and agree that, during the term of your employment by Nabi and for a period of one (1) year after termination of such employment for
any reason whatsoever, you will not, directly or indirectly, (a) engage or become interested, as owner, employee, consultant, partner, through stock ownership (except ownership of less than five percent of any class of equity securities which are
publicly traded), investment of capital, lending of money or property, rendering of services, or otherwise, either alone or in association with others, in the operations, management or supervision of any type of business or enterprise engaged in any
business which is competitive with any business of Nabi (a “Competitive Business”), (b) solicit or accept orders 
  

 4 

 from any current or past customer of Nabi for products or services offered or sold by, or competitive with products or
services offered or sold by, Nabi, (c) induce or attempt to induce any such customer to reduce such customer’s purchase of products or services from Nabi, (d) disclose or use for the benefit of any Competitive Business the name and/or
requirements of any such customer or (e) solicit any of Nabi’s employees to leave the employ of Nabi or hire or negotiate for the employment of any employee of Nabi. By way of clarification, a “Competitive Business” is not any
business or enterprise in the health care industry; it is only a business or enterprise in the health care industry that is competitive with any business of Nabi. Notwithstanding the foregoing, nothing contained in this Section 10A shall be deemed
to prohibit you from being employed by or providing services to a Competitive Business following a “Change of Control” (as defined in the Change of Control Agreement) and termination of your employment if the nature of such employment or
services do not compete with any business engaged in by Nabi immediately prior to the Change in Control. 
  
 (B) You have carefully read and considered the provisions of this Section and Section 9 and having done so, agree that the restrictions set forth (including but not limited to the time period of restriction and the
world wide areas of restriction) are fair and reasonable (even if termination is at our request and without cause) and are reasonably required for the protection of the interest of Nabi, its officers, directors, and other employees. You acknowledge
that upon termination of this Agreement for any reason, it may be necessary for you to relocate to another area, and you agree that this restriction is fair and reasonable and is reasonably required for the protection of the interests of Nabi, their
officers, directors, and other employees. 
  
 (C) In the event that,
notwithstanding the foregoing, any of the provisions of this Section or Section 9 shall be held to be invalid or unenforceable, the remaining provisions thereof shall nevertheless continue to be valid and enforceable as though invalid or
unenforceable parts had not been included therein. In the event that any provision of this Section relating to time period and/or areas of restriction shall be declared by a court of competent jurisdiction to exceed the maximum time period or areas
such court deems reasonable and enforceable, said time period and/or areas of restriction shall be deemed to become, and thereafter be, the maximum time period and/or area which such court deems reasonable and enforceable. 
  
 (D) With respect to the provisions of this Section, you agree that damages, by themselves,
are an inadequate remedy at law, that a material breach of the provisions of this Section would cause irreparable injury to the aggrieved party, and that provisions of this Section 10 may be specifically enforced by injunction or similar remedy in
any court of competent jurisdiction without affecting any claim for damages. 
  
 11. LITIGATION AND REGULATORY COOPERATION: During and after your employment with Nabi, you shall reasonably cooperate with Nabi in the defense or prosecution of any claims now in existence or which may be brought in the future
against or on behalf of Nabi which relate to events or occurrences that transpired while you were employed by Nabi; provided, however, that such cooperation shall not materially and adversely affect you or expose you to an increased probability of
civil or criminal litigation. Your cooperation in connection 
  

 5 

 with such claims or actions shall include, but not be limited to, being available to meet with counsel to prepare for
discovery or trial and to act as a witness on behalf of Nabi at mutually convenient times. During and after your employment with Nabi, you also shall cooperate fully with Nabi in connection with any investigation or review of any federal, state or
local regulatory authority as any such investigation or review relates to events or occurrences that transpired while you were employed by Nabi. Nabi shall reimburse you for all out-of-pocket costs and expenses incurred in connection with your
performance under this Section 11, including, but not limited to, reasonable attorneys’ fees and costs. 
  
 12. MISCELLANEOUS: This Agreement and the rights and obligations of the parties pursuant to it and any other instruments or documents issued pursuant to it shall be construed, interpreted and enforced in
accordance with the laws of the State of Florida, exclusive of its choice-of-law principles. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and assigns. The provisions of this
Agreement shall be severable and the illegality, unenforceability or invalidity of any provision of this Agreement shall not affect or impair the remaining provisions hereof, and each provision of this Agreement shall be construed to be valid and
enforceable to the full extent permitted by law. In any suit, action or proceeding arising out of or in connection with this Agreement, the prevailing party shall be entitled to receive an award of the reasonable related amount of attorneys’
fees and disbursements incurred by such party, including fees and disbursements on appeal. This Agreement, the Change of Control Severance Agreement and the Indemnification Agreement dated May 16, 2003 are a complete expression of all
agreements of the parties relating to the subject matter hereof, and all prior or contemporaneous oral or written understandings or agreements shall be null and void except to the extent set forth in this Agreement. 
  
 This Agreement cannot be amended orally, or by any course of conduct or dealing, but only by
a written agreement signed by the party to be charged therewith. All notices required and allowed hereunder shall be in writing, and shall be deemed given upon deposit in the Certified Mail, Return Receipt Requested, first-class postage and
registration fees prepaid, and correctly addressed to the party for whom intended at its address set forth under its name below, or to such other address as has been most recently specified by a party by one or more counterparts, each of which shall
constitute one and the same agreement. All references to genders or number in this Agreement shall be deemed interchangeably to have a masculine, feminine, neuter, singular or plural meaning, as the sense of the context required. 
  
 If the foregoing confirms your understanding of our agreements, please so indicate by signing
in the space provided below and returning a signed copy to us. 
  

 6 

			
	Nabi Biopharmaceuticals
	5800 Park of Commerce Boulevard, N.W.
	Boca Raton, Florida 33487
		
	 BY:
  
	 	  
 /s/    Thomas H. McLain

	 	 	Thomas H. McLain
	 	 	CEO and President

  

	
	 Accepted and agreed:

	
	 /s/    Raafat Fahim

 Raafat Fahim

	 1180 S. Ocean Blvd #8F

	 Boca Raton, FL 33432

  

 7Separation Agreement between InfoSpace, Inc. and Kendra VanderMuelen

 Exhibit 10.18 
  
 SEPARATION AGREEMENT 
  
 InfoSpace, Inc. (the “Company”) and Kendra VanderMeulen (“VanderMeulen”) agree to the following terms to resolve all issues with respect to
VanderMeulen’s employment with the Company and the termination thereof. 
  

	 	1.	RESIGNATION. VanderMeulen resigns her employment with the Company effective October 31, 2004 (the “Separation Date”). 

  

	 	2.	ACCRUED SALARY; BONUS. The Company will pay VanderMeulen (i) her base salary through October 31, 2004, payable on the
Company’s ordinary payroll cycle, and (ii) a pro-rated amount of any earned fourth quarter 2004 bonus consistent with the terms and conditions of the executive bonus plan at the same time as other eligible Company employees receive their
quarterly bonuses, in each case subject to standard payroll deductions and withholdings. 

  

	 	3.	SEVERANCE. The Company and VanderMeulen agree to characterize her resignation as “for Good Reason,” as defined in that certain Employment Agreement,
effective May 19, 2003, between VanderMeulen and the Company (the “Employment Agreement”). Pursuant to Section 6 of the Employment Agreement, the Company will pay VanderMeulen severance pay equal to $400,000, less lawful and required
withholdings, representing an amount equal to (i) her current base annual salary, plus (ii) an amount equal to her current annual bonus rate. The Company will pay VanderMeulen the severance pay in a lump sum on the Company’s first regular
payroll date following January 1, 2005. 

  

	 	4.	HEALTH INSURANCE. Consistent with the rights and obligations under COBRA, VanderMeulen will be eligible to continue her group health insurance
benefits at her own expense. The Company will pay her COBRA premia for a period of twelve (12) months in the amount of $5,400. The Company will pay VanderMeulen such premia in a lump sum on the Company’s first regular payroll date following the
Effective Date. 

  

	 	5.	STOCK OPTIONS. As of the Separation Date, VanderMeulen’s outstanding vested stock options shall consist of: (a) options to acquire 61,979
shares of Company stock with an exercise price of $14.10 per share, and (b) options to acquire 81,511 shares of Company stock, representing 50% of VanderMeulen’s stock options that remain unvested as of the Separation Date but whose vesting is
hereby accelerated. VanderMeulen’s unvested options shall accelerate hereunder at a pro rata amount of each of VanderMeulen’s option grants, as follows: 

  

								
	 Grant date

	  	Price

	  	Unvested

	  	50% Accelerated vesting

	 5/19/03
	  	$	14.10	  	113,021	  	56,511
	 4/1/04
	  	$	39.19	  	50,000	  	25,000

  
 VanderMeulen shall
have twelve (12) months from the Separation Date to exercise such vested shares. Except as otherwise provided herein, VanderMeulen’s stock options and all of her rights with respect thereto shall be subject to the terms of the Company’s
Restated 1996 Flexible Stock Incentive Plan and any corresponding option agreement(s). 
  

	 	6.	OTHER COMPENSATION OR BENEFITS. VanderMeulen acknowledges that, except as expressly provided in this Agreement,
VanderMeulen will not receive any additional compensation or benefits after the Separation Date. 

	 	7.	EXPENSE REIMBURSEMENTS. VanderMeulen agrees that, within thirty (30) days after the Separation Date, she will submit her final documented
expense reimbursement request reflecting all business expenses she incurred through the Separation Date, if any, for which she seeks reimbursement. The Company will reimburse VanderMeulen for these expenses pursuant to its regular business practice.

  

	 	8.	RETURN OF COMPANY PROPERTY. VanderMeulen agrees that no later than ten (10) days after the Separation Date, she
will return to the Company all Company documents (and all copies thereof) and other Company property which she has had in her possession at any time, including, but not limited to, Company files, notes, drawings, records, business plans and
forecasts, financial information, specifications, computer-recorded information, tangible property (including, but not limited to, computers), credit cards, entry cards, identification badges and keys; and any materials of any kind which contain or
embody any proprietary or confidential information of the Company (and all reproductions thereof). VanderMeulen may retain her cellular telephone and a copy of her Outlook® contacts, calendar, and personal email. 

  

	 	9.	PROPRIETARY INFORMATION AND OTHER CONTINUING OBLIGATIONS.
VanderMeulen acknowledges her continuing obligations under and reaffirms her obligation to abide by the Company’s Employee Non-Disclosure, Invention Release and Non-Competition Agreement, a copy of which is attached hereto as Exhibit A,
and any other agreement with respect to confidentiality, non-solicitation or non-competition that she entered into with the Company. 

  

	 	10.	RELEASE. In exchange for the severance benefits provided and other consideration under this Agreement to which VanderMeulen would not be entitled absent this
Release, VanderMeulen releases, acquits and forever discharges the Company, its parent and subsidiaries, and its and their respective officers, directors, agents, servants, employees, attorneys, shareholders, predecessors, successors, assigns and
affiliates, of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys’ fees, damages, indemnities and obligations of every kind and nature, in law, equity, or otherwise, known and unknown, suspected and
unsuspected, disclosed and undisclosed, arising out of or in any way related to agreements, events, acts or conduct at any time prior to and including the date she signs this Agreement, including but not limited to: all such claims and demands
directly or indirectly arising out of or in any way connected with her employment with the Company or the termination of that employment; claims or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership
interests in the Company, vacation or other time off pay, fringe benefits, expense reimbursements, severance pay, or any other form of compensation; claims pursuant to any federal, state or local law, statute, or cause of action including, but not
limited to, the federal Civil Rights Act of 1964, as amended; the federal Americans with Disabilities Act of 1990, as amended; the Age Discrimination in Employment Act, any applicable federal, state or local law prohibiting discrimination in
employment, as amended; tort law; contract law; wrongful discharge; discrimination; harassment; fraud; defamation; emotional distress; and breach of the implied covenant of good faith and fair dealing and specifically including all claims arising
from any employment agreement or stock restriction agreement; provided that this Release is not intended to and does not waive VanderMeulen’s rights: (a) to indemnification pursuant to any applicable provision of the Company’s Bylaws or
Certificate of Incorporation, as amended, pursuant to the written indemnification agreement between VanderMeulen and the Company referenced in Section 13 below, or pursuant to applicable law; (b) to vested benefits or payments specifically to be
provided to VanderMeulen under any Company employee benefit plans or policies; 

  

 2 

 (c) respecting any claims which VanderMeulen may have solely by virtue of her status as a shareholder of
the Company; or (d) respecting any claims by VanderMeulen for defamation, libel or slander. 
  

	 	11.	RELEASE OF ADEA CLAIMS. VanderMeulen acknowledges that, by this Agreement, she is knowingly and voluntarily
waiving and releasing any rights she may have under the Age Discrimination in Employment Act (ADEA) as amended. VanderMeulen also acknowledges that the consideration given for the waiver and release in the preceding paragraph hereof is in addition
to anything of value to which she is already entitled. VanderMeulen further acknowledges that she has been advised by this writing, as required by the ADEA, that: (a) her waiver and release does not apply to any rights or claims that may arise after
the execution date of this Agreement; (b) she should consult with an attorney prior to executing this Agreement; (c) she has twenty-one (21) days to consider this Agreement (although she may choose to voluntarily execute this Agreement earlier and
if she does, she waives the remainder of the 21 days to consider this Agreement); (d) she has seven (7) days following the execution of this Agreement by the parties to revoke the Agreement; and (e) this Agreement will not be effective until the
date upon which the revocation period has expired, which will be the 8th day after this Agreement is executed by VanderMeulen (the “Effective Date”). 

  

	 	12.	NONDISPARAGEMENT. The Company and VanderMeulen shall both describe VanderMeulen’s separation from the Company as a resignation from VanderMeulen’s
position at the Company. VanderMeulen agrees not to disparage the Company, its officers and directors, employees or shareholders, by any statement that can reasonably be anticipated to be harmful to the Company or the individuals, provided that
VanderMeulen may respond accurately and fully to any question, inquiry or request when required by law or otherwise participate in any legal process. The Company and its officers and directors shall not, in any official or representative capacity,
disparage VanderMeulen by any statement that can reasonably be anticipated to be harmful to VanderMeulen or her reputation, provided however the Company and its officers and directors may respond accurately and fully to any question, inquiry or
request for information when required by law or otherwise participate in any legal process. 

  

	 	13.	INDEMNIFICATION OBLIGATIONS. The Company acknowledges its continuing obligations under the Indemnification
Agreement dated May 19, 2003 between the Company and VanderMeulen. 

  

	 	14.	ARBITRATION. VanderMeulen and the Company agree that any dispute regarding the interpretation or enforcement of this Agreement or any dispute arising out of
her employment or the termination of that employment with the Company, except for disputes involving the protection of the Company’s intellectual property, shall be decided by confidential, final and binding arbitration conducted by Judicial
Arbitration and Mediation Services (“JAMS”) in King County, Washington under the then-existing JAMS rules, rather than by litigation in court, trial by jury, administrative proceeding, or in any other forum. The Company agrees to bear the
cost of arbitration; however, each party shall bear its own costs including attorneys’ fees incurred with respect to such arbitration, except that the arbitrator thereunder shall have the authority to award the prevailing party its reasonable
attorneys’ fees. Nothing in this paragraph is intended to prevent either VanderMeulen or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. 

 

 3 

	 	15.	VOLUNTARY AGREEMENT. VanderMeulen agrees that she enters into this Agreement as a free and voluntary act and signs it only after full reflection
and analysis. VanderMeulen further acknowledges that she has obtained an attorney’s independent counsel and advice or has voluntarily elected not to do so. VanderMeulen acknowledges that she has read and understands the complete Agreement.

  

	 	16.	MISCELLANEOUS. This Agreement constitutes the complete, final and exclusive embodiment of the entire agreement between VanderMeulen and the
Company with regard to this subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations.
This Agreement may not be modified or amended except in a writing signed by both VanderMeulen and a duly authorized officer of the Company. This Agreement shall bind the heirs, personal representatives, successors and assigns of VanderMeulen and the
Company, and inure to the benefit of VanderMeulen and the Company, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any
other provision of this Agreement and the provision in question shall be modified by the court so as to be rendered enforceable. This Agreement shall be deemed to have been entered into and shall be construed and enforced in accordance with the laws
of the State of Washington as applied to contracts made and to be performed entirely within Washington. 

  

			
	INFOSPACE, INC.	  	EMPLOYEE
		
	 /s/ James F. Voelker

	  	 /s/ Kendra VanderMeulen

	James F. Voelker, Chief Executive Officer	  	Kendra VanderMeulen
	DATED: October 22, 2004	  	DATED: October 22, 2004

  

 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00073-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00073-of-00352.parquet"}]]